Syncona (LON:SYNC) Hits New 52-Week High – Time to Buy?

Syncona (LON:SYNC) shares reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 110.02 and last traded at GBX 110, with a volume of 8624 shares changing hands. The stock had previously closed at GBX 109.40.

Analyst Upgrades and Downgrades

Separately, Peel Hunt reaffirmed a “buy” rating and issued a GBX 189 target price on shares of Syncona in a research report on Tuesday, August 4th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of GBX 189.

Syncona Stock Up 0.2%

The stock has a market capitalization of £666.62 million, a PE ratio of -75.59 and a beta of 0.36. The stock’s 50-day moving average is GBX 105.24 and its 200 day moving average is GBX 98.21.

Insider Activity

In related news, insider John Roche purchased 16,063 shares of the stock in a transaction dated Friday, June 19th. The shares were acquired at an average cost of GBX 100 per share, for a total transaction of £16,063. 0.75% of the stock is owned by company insiders.

Syncona Company Profile

Syncona’s purpose is to invest to extend and enhance human life. We do this by creating, building and scaling companies to deliver transformational treatments to patients in areas of high unmet need. We aim to build and maintain a diversified portfolio of 20-25 globally leading life science businesses, across development stage, modality and therapeutic area, for the benefit of all our stakeholders. We focus on developing treatments that deliver patient impact by working in close partnership with world-class academic founders and experienced management teams.